Sign up
Healthed-White-on-Blue
joshua trigg

Dr Joshua Trigg

Researcher and Lecturer in Public Health, Flinders University
Dr Joshua Trigg is a public health researcher with training and experience in psychological and population health research. His work focuses on health and occupational health risk factors, risk attitudes and motivators of risk behaviours.Dr Trigg came to the Flinders Public Health Team from Cancer Council South Australia, where he researched tobacco and alcohol use attitudes and behaviours, as well as community perceptions of culturally focused tobacco cessation messaging. His previous work has examined motivators and inhibitors of emergency risk taking behaviour, and wellbeing and quality of life domains, and has used various quantitative and qualitative methods.He is a member of the Australasian Professional Society on Alcohol and other Drugs and Public Health Association of Australia, and has worked with government health bodies, non-profits and various community organisations across Australia. His current research interests include:– Tobacco control and smoking cessation – Vaping and e-cigarette use – Alcohol consumption patterns – Health risk behaviours – Health promotion/risk messaging effectiveness – Wellbeing and quality of lifeQualifications – PhD (Psychology) – BPsycSci(Hon) (First Class)

More from this expert

Unhappy,Young,Woman,Sit,On,Sofa,At,Home,Have,Problems

Vaping and mental health are closely linked. That can make quitting even harder

With growing awareness of the effects of vaping on health plus recent reforms to limit availability of vapes to pharmacies in Australia, many people will be thinking about quitting. They will also need support to do so.

By Dr Joshua Trigg, A/Prof Anthony Venning, Dr Lavender Otieno
Clinical Articles iconClinical Articles

Discover

Healthed

CPD platform

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.

Register for webcast